Laird Norton Wetherby Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,625
Closed -$1.45M 735
2019
Q3
$1.45M Buy
14,625
+186
+1% +$17.7K 0.15% 154
2019
Q2
$1.33M Buy
14,439
+1,624
+13% +$154K 0.15% 154
2019
Q1
$1.21M Buy
12,815
+1,932
+18% +$169K 0.15% 142
2018
Q4
$697K Sell
10,883
-1,343
-11% -$99.1K 0.1% 237
2018
Q3
$1.09M Buy
12,226
+369
+3% +$32.6K 0.14% 173
2018
Q2
$942K Buy
11,857
+603
+5% +$50.1K 0.13% 183
2018
Q1
$1M Sell
11,254
-2,267
-17% -$218K 0.14% 176
2017
Q4
$1.41M Sell
13,521
-1,280
-9% -$144K 0.2% 110
2017
Q3
$2.16M Buy
14,801
+904
+7% +$123K 0.32% 66
2017
Q2
$1.8M Sell
13,897
-1,130
-8% -$138K 0.31% 66
2017
Q1
$1.87M Buy
15,027
+270
+2% +$32.3K 0.34% 63
2016
Q4
$1.71M Buy
14,757
+348
+2% +$38.8K 0.33% 59
2016
Q3
$1.51M Buy
14,409
+2,199
+18% +$238K 0.3% 62
2016
Q2
$1.2M Buy
12,210
+833
+7% +$86.2K 0.27% 81
2016
Q1
$1.14M Buy
11,377
+373
+3% +$38.4K 0.27% 80
2015
Q4
$1.32M Sell
11,004
-1,257
-10% -$145K 0.32% 66
2015
Q3
$1.33M Buy
12,261
+650
+6% +$80.7K 0.34% 62
2015
Q2
$1.34M Buy
11,611
+273
+2% +$31.2K 0.32% 65
2015
Q1
$1.31M Buy
11,338
+228
+2% +$27.2K 0.32% 65
2014
Q4
$1.24M Sell
11,110
-107
-1% -$11.3K 0.31% 64
2014
Q3
$1.06M Buy
11,217
+241
+2% +$21.7K 0.3% 73
2014
Q2
$942K Sell
10,976
-286
-3% -$21.7K 0.27% 86
2014
Q1
$786K Sell
11,262
-436
-4% -$34.5K 0.23% 103
2013
Q4
$988K Buy
11,698
+1,096
+10% +$86.7K 0.28% 82
2013
Q3
$817K Buy
10,602
+720
+7% +$50.5K 0.25% 93
2013
Q2
$578K Buy
+9,882
New +$595K 0.2% 116

Other funds holding CELG

Laird Norton Wetherby Wealth Management's CELG Position: Q4 2019 in Review

Laird Norton Wetherby Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,625 shares — an estimated $1.45M sold.

Laird Norton Wetherby Wealth Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.16M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Laird Norton Wetherby Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 14,625 Celgene Corp shares in Q4 2019, an estimated $1.45M.
  • Laird Norton Wetherby Wealth Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Laird Norton Wetherby Wealth Management's Celgene Corp position peaked at $2.16M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q4 2019, filed 28 Jan 2020.